Loading stock data…
$9.41-0.53 (-5.33%)
MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases.
MeiraGTx Holdings plc in the Healthcare sector is trading at $9.41 with a market capitalization of $1.3B. Wall Street consensus targets $27.75 (8 analysts), implying a +194.9% move over the next 12 months. The stock is currently 39% below its 52-week high of $15.35, remaining 7.7% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 26 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $321.43M↑ | $293,000↓ | $75.36M↑ | $410,000↓ | $3.69M |
| Gross Profit | $314.27M↑ | $95,000↓ | $74.89M↑ | $97,000↓ | $1.01M |
| Operating Income | $244.43M↑ | -$40.82M↓ | $26.47M↑ | -$46.05M↓ | -$44.79M |
| Net Income | $160.72M↑ | -$46.31M↓ | $15.09M↑ | -$50.51M↓ | -$38.80M |
MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degene...